HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John E Scott Selected Research

Amoxapine (Asendin)

7/2014Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity.
8/2012Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John E Scott Research Topics

Disease

6Neoplasms (Cancer)
01/2018 - 11/2010
4Diarrhea
07/2014 - 11/2010
3Neoplasm Metastasis (Metastasis)
01/2018 - 04/2013
3Atherosclerosis
07/2010 - 11/2008
2Triple Negative Breast Neoplasms
01/2020 - 04/2014
2Drug-Related Side Effects and Adverse Reactions
07/2014 - 11/2010
1Breast Neoplasms (Breast Cancer)
01/2020
1Colonic Neoplasms (Colon Cancer)
11/2010
1Chronic Pain
06/2009
1Osteoarthritis
08/2006
1Shock
08/2006
1Mycoses (Diseases, Fungus)
08/2004
1Inflammation (Inflammations)
05/2002

Drug/Important Bio-Agent (IBA)

5EnzymesIBA
07/2014 - 11/2008
4Phosphotransferases (Kinase)IBA
01/2018 - 08/2004
4Irinotecan (Camptosar)FDA LinkGeneric
07/2014 - 11/2010
3Pharmaceutical PreparationsIBA
07/2014 - 11/2010
3OrganophosphatesIBA
07/2010 - 11/2008
2GlucuronidaseIBA
07/2014 - 08/2012
2Amoxapine (Asendin)FDA Link
07/2014 - 08/2012
2HDL LipoproteinsIBA
07/2010 - 05/2010
1Drug CombinationsIBA
01/2020
17-ethyl-10-hydroxycamptothecin beta-glucuronideIBA
07/2014
1Dasatinib (BMS 354825)FDA Link
04/2014
1bosutinibIBA
04/2014
1IsocarboxazidFDA Link
08/2012
1NialamideIBA
08/2012
1Aryldialkylphosphatase (Paraoxonase)IBA
05/2010
1Protein Isoforms (Isoforms)IBA
06/2009
1Aggrecans (Aggrecan)IBA
08/2006
1beta-1,3-glucanIBA
08/2004
1Biological ProductsIBA
05/2002

Therapy/Procedure

6Therapeutics
01/2020 - 08/2004
1Oral Administration
07/2014
1Drug Therapy (Chemotherapy)
08/2012